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Abstract
Background Fever in neurocritical care patients is com-
mon and has a negative impact on neurological outcome.
The purpose of this prospective observational study was
(1) to evaluate the practicability of cooling with newly
developed neck pads in the daily setting of neurointensive
care unit (NICU) patients and (2) to evaluate its effec-
tiveness as a surrogate endpoint to indicate the feasibility
of neck cooling as a new method for intractable fever.
Methods Nine patients with ten episodes of intractable
fever and aneurysmal subarachnoid hemorrhage were
treated with one of two different shapes of specifically
adapted cooling neck pads. Temperature values of the
brain, blood, and urinary bladder were taken close meshed
after application of the cooling neck pads up to hour 8.
Results The brain, blood, and urinary bladder tempera-
tures decreased significantly from hour 0 to a minimum in
hour 5 (P < 0.01). After hour 5, instead of continuous
cooling in all the patients, the temperature of all the three
sites remounted.
Conclusion This study showed the practicability of local
cooling for intractable fever using the newly developed
neck pads in the daily setting of NICU patients.
Keywords Fever  Local cooling  Neck pads 
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Introduction
Fever occurs with an incidence of up to 70% in neuro-
logically injured patients. To reduce fever-related
secondary brain damage and to improve clinical outcome,
the temperature of the brain needs to be monitored and
strictly controlled [1–7]. One of the key centers of ther-
moregulation of the human body represents the medial
preoptic anterior hypothalamic area (POA), influenced by
multiple thermoreceptors, feed forward reflex pathways,
feedback mechanisms, and pyrogenic mediators [1, 7–11].
Furthermore, the POA is supplied by dendrites ending
in the third ventricle and getting information of all the
ascending thermoreceptive, pathways as well as endoge-
nous signals in the cerebrospinal fluid [8, 9] (Fig. 1).
There are various possibilities to intervene in this
thermoregulation by external devices. Compared to an
intravascular cooling method, which is efficient and fast,
but invasive and with several relevant side effects such as
venous thrombosis or cause of infections, the advantage of
a local cooling device becomes obvious. For specific
cooling of the deep brain, head caps are not efficient
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[12–14], whereas neck pads covering bilateral the carotid
triangle decrease the brain temperature in a mathematical
simulation [13, 15]. In a previous study, we simulated
cerebral temperature behavior by applying different cooling
devices [13]. They simulated cerebral temperature behavior
with hypothermia treatment applying different cooling
devices. The models were based on hourly temperature
values recorded in patients with severe aneurysmal
subarachnoid hemorrhage (aSAH), taking into account
magnetic resonance imaging data, thermal conductive
properties, metabolism, and blood flow, and were applied to
different scenarios of hypothermia. In summary, systemic
hypothermia by endovascular cooling leads to a uniform
temperature decrease within the brain tissue. Cooling with
head caps lead to 33C only in the superficial brain, while the
deep brain remains higher than 36C. In contrast cooling
with neck pads, covering the carotid triangles, lead to 35.8C
for dry, and 32.8C for wet skin in the deep brain within 6 h.
The equation of the mathematical model included temper-
ature-dependent blood perfusion, cerebral metabolic rate,
and time-dependent arterial blood temperature [13].
These findings encouraged us to create new shapes of
cooling devices for selective cooling of the carotid trian-
gles to attempt to decrease the brain temperature in patients
with fever resisting conventional methods. The purpose of
this observational study was to evaluate the practicability
of cooling with newly developed neck pads in the daily
setting of neurointensive care unit (NICU) patients and its
effectiveness as a surrogate endpoint to indicate the feasi-
bility of neck cooling as a new method for intractable
fever.
Methods
This prospective study was approved by the local ethics
committee and followed institutional guidelines.
Two shapes of neck pads for covering the carotid tri-
angles with a contact surface as large as possible have been
developed. These neck pads were effective in cooling the
blood inflow within the carotid arteries neither limiting the
patient care and comfort nor venous drainage. The first
shape was created for standard-sized necks. The second
shape of the neck pads was created to fit patients with a
short neck or a tracheostoma, with a smaller width in
general and above all in the middle section (Fig. 2a, b).
Corresponding to our mathematical simulations, the heat
transfer coefficient (htc) in these pads was about 22.4 watts
per meter squared-kelvin (W/(m2K)) with a mathematical
optimal htc of 28 W/(m2K). Tissue density, tissue specific
heat coefficients, blood perfusion rate, heat source of the
natural metabolism, and further values were implemented
in the mathematical equation representing the thermal
behavior of the different tissues and blood, which was
developed in the previous study [13] and transferred in this
practical observational study. The ArcticSun Temperature
Management System (Medivance, Louisville CO) was
used, employing hydrogel-coated water-circulating energy
transfer pads to allow an intimate adhesion to the patient’s
skin and a similar heat exchange coefficient as in a water
bath [16]. The cooling system was set to the automatic
mode with the desired patient target temperature of 36.8C
working continuously with maximal cooling capacity.
The lowest water temperature was 5C. The water flow
Fig. 1 Simplified cascade of
thermoregulatory pathways
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through the neck pads was accelerated by a shunt-line
parallel to the neck pad flow, resulting in a continuous flow
between 1.7 l/min and 2.3 l/min.
Inclusion criteria of our nine consecutive patients were
having a brain temperature probe and presenting episodes
of intractable fever (n = 10) within 4 weeks after aSAH.
Patient demographics are summarized in Table 1. Our
standard treatment protocol of patients with aSAH is
described by Lerch et al. [17]. Each patient was treated
with one of the specific neck pads. Intractable fever was
defined as a temperature >37.8 persistent after 2 h of
expanded standard fever management with application of
acetaminophen (1 gm every 6 h), novaminsulfone (1 gm
every 6 h), specific washing solutions (mixture of yellow
lemon, bergamot, cajeput oil, star eucalyptus, added by
water), and ice packs (inguinal).
Overall 459 temperature values of the brain (Tbrain),
blood (Tblood), and urinary bladder (Tbladder) were taken
every 15 min over a period of 2 h, every 30 min until
hour 4 and hourly up to hour 8, after application of the
cooling neck pads. Tbrain was continuously recorded via a
thermistor embedded in the ventricular drainage (Neuro-
vent-P Temp, Raumedic), in addition to continuous
temperature measurement of the arterial blood (Pulsiocath
Thermodilution catheter, Pulsion Medical Systems AG)
and the urinary bladder via indwelling catheter (Foley
Catheter with temperature sensor, Curity, Kendall, tyco
Healthcare).
Patients with remounting temperatures after the 8 h of
applied neck pads were treated either by adding leg or body
pads of the ArcticSun system or by placing an intravas-
cular cooling system.
All the patients were monitored carefully for possible side
effects related to the application of the neck pads. Side
effects were defined as skin irritation, pressure marks, wound
infection, disturbances in wound healing of a new trache-
ostomy, or shivering. Shivering, defined as involuntary,
oscillatory muscular activity, and cutaneous vasoconstric-
tion [18] was assessed together with each taken temperature
value at fixed times as mentioned above and documented as
absent, mild, or severe. Changes of the analgetic or sedative
medication, changes in arterial blood pressure, and heart rate
were documented at least hourly following the standard
treatment protocol.
Temperature values are given in mean C ± standard
deviation. All the temperature values of the three
Fig. 2 Cooling neck pads with afferent and efferent suction of cool
water from the right side. a regular shape b shape for short necks and/
or tracheostoma
Table 1 Patient demographics
Female 4
Male 5
Age (years) 48.7 ± 9
Hunt & Hess 3.3 ± 1.0
Fisher Grade 3.4 ± 0.5
WFNS 3.2 ± 1.6
Clipping 4
Coiling 5
Fever post-SAH (days) 8.3 ± 5.9
Infection 8
Central fever 2
Vigilance on ‘‘neck pad day’’
GCS C 13 1
Comatose 8
Analgosedation 7
Fentanyl 5
Midazolam 5
Thiopental 1
Propofol 2
Spontaneous breathing 2
Artificial ventilation 7
Oral intubation 5
Tracheostoma 3
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compartments before and after cooling, as well as the
temperature values between brain, blood, and urinary
bladder were compared using a paired Wilcoxon Mann–
Whitney U-test.
Results
The brain temperature decreased significantly after 5 h
with neck pad cooling from 38.2 ± 0.3 (hour 0) to a
minimum of 37.7 ± 0.3 (hour 5) (P < 0.01). Comparably
Tblood and Tbladder decreased significantly from hour 0
to a minimum in hour 5 from 38.1 ± 0.3 to 37.7 ± 0.2 and
from 38.3 ± 0.4 to 37.8 ± 0.3, respectively (P < 0.01).
After hour 5, instead of continuous cooling, in all the
patients the temperature of the brain remounted (Fig. 3).
The cooling system was set to the automatic mode
maintaining 5C after achievement of steady-state status
during the study period in all the patients.
In eight fever episodes of seven patients the performed
standard methods in fixed intervals for lowering tempera-
ture (see above) were continued during the neck pad
application without any systematic lasting decline in
temperature (38.1 ± 0.4 before medicaments (n = 8) or
washing (n = 4), respectively, and 38.0 ± 0.3 after 1 hour
of one of these interventions; (n = 12)).
No shivering and no side effects as defined above related
to the neck pad cooling technique occurred. Furthermore,
no increase of ICP as a potential worsening of jugular
venous drainage occurred, no related changes in blood
pressure or heart rate were observed, and a tracheostoma
was not debilitating. The analgosedation of the patients
Fig. 3 Three diagrams showing
the data of all the temperatures
(T in C) taken in the blood,
brain, or urinary bladder over a
period of 8 h after application of
the neck pad device, with
shorter time intervals at the
beginning. Bold black line and
bars: Bold line represents the
mean of the temperatures, the
bars demonstrate the
mean ± standard deviation
from hour 0 (before application
of the neck pad cooling) to
hour 8 (after start of the neck
pad cooling). Fine lines: Each
fine blue line represents one
fever episode with each
registered value before (hour 0)
and after application of the neck
pad (until hour 8). The red line
represents the median. Numbers
above each diagram from the
left to the right: Mean hour 0
and standard deviation Mean
hour 5 and standard deviation
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ranged between deep comatose and awake with slight
analgosedation (Table 1). No change of analgosedation
was performed during the study period.
Discussion
Choosing patients with aneurysmal subarachnoid hemor-
rhage, provides a group of patients at high risk for fever,
who are most difficult to treat [1]. After application of
various antipyretics and cool washing solutions the neck
pads could significantly decrease the temperature of the
brain, blood, and urinary bladder, respectively. Although
the cooling result was significant, the amount of tempera-
ture decrease was small. We studied nine consecutive
patients with intractable fever with random neck sizes and
created two shapes of neck pad devices, to achieve a more
flexible fit to the various neck types. The neck pads were
applicable in every neck constitution of our patients.
We observed no side effects and no shivering as defined
in the method section. Possible explanations for the lack of
shivering in our patient group might be the small covered
area by the neck pads, the small amount of temperature
decline and analgosedation in most of the patients.
Furthermore, in all our patients serum magnesium levels
were close to the upper limit [18], following our standard
treatment protocol of aSAH [17]. Despite concerns of an
accidental obstruction of the jugular venous drainage or
triggering of autonomous dysfunctions via vulnerable
structures like the glossopharyngeal and vagal nerves
or carotid bodies, we did not observe any relevant changes
concerning these issues during the study period after
application of the neck pads. Applying the neck pads as
local cooling devices, one should keep in mind that it
seems to present not only local, but also systemic hypo-
thermic effects. This could also be assumed by our results
of simultaneous behavior of the temperatures in all the
three locations (brain, urinary bladder, blood) and might be
associated with systemic side effects.
Illustrated in Fig. 3, there are two episodes of
remounting temperatures. Regarding the short-term tem-
perature increase in our patients after the same delay time
after the start of the neck pad device application, sponta-
neous fever variations seem to be unlikely. The hypothesis
of a counterregulation provoked by treatment of fever was
discussed by Keller et al. [13] based on the mathematical
models. The origin and mechanisms of thermoregulation of
brain and body are very complex and the exact causes of
set-point changes are discussed controversially [19–21].
Performing a kind of interval cooling to avoid or reduce
triggering of potential counterregulation could be an
alternative approach to attempt to extend the period of
normalized brain temperature. But it would be very
difficult to define the most efficient on-/off-time episodes
for cooling, as well as the consideration of all the unstable
components. To the best of our knowledge, there is no
mathematical model to simulate the reaction of fever
treatment and counterregulation. In eight of ten fever epi-
sodes the patients received additional applications to the
cooling neck pads, such as acetaminophen, novaminsulfone
or specific washing, independently of the first early
remount of temperature. The antipyretics were given in
standardized fixed intervals and continued as analgetic
drugs when it came to the decision to apply the neck pads.
We inspected the temperature values across the whole
range during each of the 12 washing and pharmacological
interventions and compared it with the following data
points without observing a marked effect. A circadian
rhythm of body temperature with 12 h between lowest and
peak temperature seems not to be relevant in our study
period of 8 h and shorter segments of remounting
temperatures.
In contrast to other studies [12, 20, 22], the brain tem-
perature in our evaluation was not consistently higher than
in the arterial blood or in the urinary bladder. Nevertheless,
monitoring of the brain temperature with thermistors in the
ventricular system or in the deep brain parenchyma (at least
2 cm below the cortical surface [13]) is essential to study
the effectiveness of new devices for selective cerebral
cooling.
Because of the description of the higher temperature in
any brain structure than in the rest of the body, as well as
the faster and more obvious changes of temperature in the
brain [22, 23], there is a necessity to use specific devices to
cool especially the brain. An increase in blood temperature
would heat the well-perfused brain rapidly, and a decrease
in blood temperature would lead to a rapid decrease of the
brain temperature, respectively [23]. As shown in other
studies selective brain cooling with a cap is not sufficient,
for which reason the future selective cooling devices
should be restricted to cooling the arterial flow of the neck
[13, 15, 24, 25].
The idea to develop new devices for selective neuro-
protective cooling of the brain parenchyma has already
been published [12, 26–32]. In each of the studies, the
device became more specific and smaller [33]. Future
improvements of the local cooling system must be per-
formed with the intention to improve the material
properties of the neck pads concerning the contact surface
and the heat transfer coefficients.
Limitations
Concerning this new neck pad device several limitations
have to be discussed. We studied nine consecutive patients
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without classifying the neck type in slim, thick, and short
necks. The study is limited by only a small number of
patients and fever episodes and no control group. No
extended monitoring values such as CO2, detailed changes
of heart rate, blood pressure, or respiration were taken into
account in this first evaluation study. Having small tem-
perature decreases and continuing standard fever treatment
in a small patient group makes it difficult to differentiate
between the definitive effect of the neck pads and sponta-
neous fever curve.
In future studies with an optimized neck pad and a larger
number of patients, including a control group, a differen-
tiation between different neck sizes is recommended.
Conclusion
This study showed the practicability of local cooling for
intractable fever using the newly developed neck pads in
the daily setting of NICU patients.
Representing the first observational study without the
use of a control group, it is not possible to determine
whether selective cooling of the neck with these pads might
be efficient in decreasing intractable fever and sustaining
normothermia over a prolonged period.
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